Mankind Pharma Limited (BOM:543904)

India flag India · Delayed Price · Currency is INR
2,423.15
-39.95 (-1.62%)
At close: Mar 28, 2025
3.86%
Market Cap 1.00T
Revenue (ttm) 116.41B
Net Income (ttm) 20.41B
Shares Out n/a
EPS (ttm) 50.81
PE Ratio 49.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 27,991
Average Volume 16,654
Open 2,459.00
Previous Close 2,463.10
Day's Range 2,411.90 - 2,484.30
52-Week Range 1,910.10 - 3,050.00
Beta n/a
RSI 56.79
Earnings Date May 15, 2025

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and m... [Read more]

Industry Pharmaceutical Preparations
Founded 1991
Employees 19,540
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543904
Full Company Profile

Financial Performance

In 2023, Mankind Pharma's revenue was 103.35 billion, an increase of 18.12% compared to the previous year's 87.49 billion. Earnings were 19.13 billion, an increase of 49.23%.

Financial Statements

News

There is no news available yet.